Guggenheim Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
|
|||||
|
2025
Q1 | $2.42M | Sell |
|
|||||
|
2024
Q4 | $2.48M | Sell |
|
|||||
|
2024
Q3 | $2.81M | Sell |
|
|||||
|
2024
Q2 | $3.4M | Sell |
|
|||||
|
2024
Q1 | $4.02M | Buy |
|
|||||
|
2023
Q4 | $4.01M | Sell |
|
|||||
|
2023
Q3 | $4M | Sell |
|
|||||
|
2023
Q2 | $4.3M | Buy |
|
|||||
|
2023
Q1 | $4.17M | Sell |
|
|||||
|
2022
Q4 | $4.96M | Buy |
|
|||||
|
2022
Q3 | $3.89M | Sell |
|
|||||
|
2022
Q2 | $4.64M | Sell |
|
|||||
|
2022
Q1 | $4.54M | Sell |
|
|||||
|
2021
Q4 | $5.83M | Buy |
|
|||||
|
2021
Q3 | $4.94M | Buy |
|
|||||
|
2021
Q2 | $5.25M | Sell |
|
|||||
|
2021
Q1 | $4.91M | Buy |
|
|||||
|
2020
Q4 | $5.42M | Sell |
|
|||||
|
2020
Q3 | $8.24M | Sell |
|
|||||
|
2020
Q2 | $13.9M | Buy |
|
|||||
|
2020
Q1 | $8.83M | Sell |
|
|||||
|
2019
Q4 | $10.5M | Buy |
|
|||||
|
2019
Q3 | $7.67M | Sell |
|
|||||
|
2019
Q2 | $9.94M | Sell |
|
|||||
|
2019
Q1 | $10.9M | Buy |
|
|||||
|
2018
Q4 | $9.94M | Sell |
|
|||||
|
2018
Q3 | $11.9M | Sell |
|
|||||
|
2018
Q2 | $12.1M | Sell |
|
|||||
|
2018
Q1 | $10.7M | Buy |
|
|||||
|
2017
Q4 | $11.6M | Sell |
|
|||||
|
2017
Q3 | $13.8M | Buy |
|
|||||
|
2017
Q2 | $13M | Buy |
|
|||||
|
2017
Q1 | $12.3M | Buy |
|
|||||
|
2016
Q4 | $11.5M | Sell |
|
|||||
|
2016
Q3 | $13.6M | Sell |
|
|||||
|
2016
Q2 | $11.7M | Buy |
|
|||||
|
2016
Q1 | $12.4M | Sell |
|
|||||
|
2015
Q4 | $19.9M | Sell |
|
|||||
|
2015
Q3 | $22.5M | Buy |
|
|||||
|
2015
Q2 | $28.1M | Buy |
|
|||||
|
2015
Q1 | $23.2M | Buy |
|
|||||
|
2014
Q4 | $14.8M | Buy |
|
|||||
|
2014
Q3 | $11.1M | Buy |
|
|||||
|
2014
Q2 | $9.49M | Sell |
|
|||||
|
2014
Q1 | $11.8M | Buy |
|
|||||
|
2013
Q4 | $10.9M | Sell |
|
|||||
|
2013
Q3 | $11.5M | Sell |
|
|||||
|
2013
Q2 | $10.6M | Buy |
|